Promethera Brings in $23M for Liver Stem Cell Therapy
Promethera Biosciences SA raised €17 million (US$22.7 million) in a Series B round last week to fund the first clinical trials of its allogeneic stem cell therapy for pediatric and adult liver disorders. It also received a further €6.6 million in loan financing from Belgium's Walloon region.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter